Summary
This Bristol-Myers Squibb (BMY) 8-K filing from June 2, 2006, announces the submission of its first quarter 2006 financial information formatted in XBRL (Extensible Business Reporting Language). This filing is primarily a technical submission to test the XBRL format and technology, not to present official audited financial statements for investment decisions. Investors are strongly cautioned that the XBRL data included as Exhibit 100 is unaudited and should not be relied upon for making investment decisions. The company directs investors to rely on the official, previously filed versions of its financial reports, specifically the Form 10-Q for the quarter ended March 31, 2006, filed on May 8, 2006. This filing is not intended to create new liabilities under Section 18 of the Exchange Act.
Key Highlights
- 1Bristol-Myers Squibb is testing XBRL formatting for financial reporting.
- 2The filing includes unaudited financial information from the Q1 2006 10-Q in XBRL format (Exhibit 100).
- 3Investors are advised to rely on the official filed financial statements, not the XBRL data for investment decisions.
- 4This XBRL submission is for technology testing purposes.
- 5The information furnished is not considered 'filed' for purposes of Section 18 of the Exchange Act.
- 6The filing date is June 2, 2006, with the earliest event date of May 8, 2006 (related to the 10-Q filing).